• FirefoxUpgrade to the new Firefox »
  •  Dow Down 0.02% Nasdaq Up 0.19%

    Kythera Biopharmaceuticals, Inc. (KYTH)

    -NasdaqGS
    35.34 Down 0.17(0.48%) 11:54AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:35.51
    Open:35.43
    Bid:35.35 x 200
    Ask:35.40 x 100
    1y Target Est:53.20
    Beta:0.06
    Earnings Date:Mar 16 - Mar 20 (Est.)
    Day's Range:34.90 - 35.83
    52wk Range:29.50 - 56.36
    Volume:112,440
    Avg Vol (3m):191,712
    Market Cap:801.33M
    P/E (ttm):N/A
    EPS (ttm):-5.68
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for KYTH

    Comparison

    Symbol% ChgMkt Cap
    KYTHDown 0.48%801.33M
    ZLTQDown 0.78%1.11B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-3.62
    Quarterly EPS Est (Dec-14) :-1.04
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):-0.62

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    KYTHERA Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of prescription products for the aesthetic medicine market. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback